Planned, ongoing and completed tuberculosis treatment trials in Brazil, Russia, India, China and South Africa: A 2019 cross-sectional descriptive analysis

dc.contributor.authorMathebula, Lindi
dc.contributor.authorMapahla, Lovemore
dc.contributor.authorJordan, Esme
dc.date.accessioned2022-07-12T08:01:21Z
dc.date.available2022-07-12T08:01:21Z
dc.date.issued2022
dc.description.abstractTuberculosis (TB) remains a deadly challenge globally and Brazil, Russia, India, China and South Africa (BRICS) are among the countries with the highest TB burden. The objective of this study is to identify and describe ongoing, planned and completed TB trials conducted in the BRICS countries registered in WHO-International Clinical Trial Registry Platform (WHO-ICTRP); to report selective outcome reporting by comparing primary outcomes in published trials with their prespecified outcomes in registry records and to evaluate the time to publication.en_US
dc.identifier.citationMathebula, L. et al. (2022). Planned, ongoing and completed tuberculosis treatment trials in Brazil, Russia, India, China and South Africa: A 2019 cross-sectional descriptive analysis. . BMJ Open, 12, e057941. 10.1136/ bmjopen-2021-057941en_US
dc.identifier.issn2044-6055
dc.identifier.uri10.1136/bmjopen-2021-057941
dc.identifier.urihttp://hdl.handle.net/10566/7588
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectClinical trialsen_US
dc.subjectTuberculosisen_US
dc.subjectSustainable Development Goalsen_US
dc.subjectBRICSen_US
dc.subjectPublic healthen_US
dc.titlePlanned, ongoing and completed tuberculosis treatment trials in Brazil, Russia, India, China and South Africa: A 2019 cross-sectional descriptive analysisen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
mathebula_planned, ongoing and completed tuberculosis treatment_2022.pdf
Size:
579.65 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: